SPON2 and prostate carcinoma: To test whether there is an association between MINDIN and the osteogenic-related factor NHERF-1 in prostate cancer, we first analyzed by immunohistochemistry the expression and subcellular localization of MINDIN and NHERF-1 in human prostate control and tumor samples.